Article by John Flint, PerthNow
Perth researchers are to test whether medical cannabis can pave a breakthrough in the treatment of pancreatic cancer, one of the most lethal diseases on the planet.
Curtin University’s School of Biomedical Sciences is poised to start testing cannabis formulations against human pancreatic cell cancer lines grown in the laboratory.
The project is in collaboration with Zelda Therapeutics, a Perth-based biopharmaceutical company, which will import the cannabis from Canada.
The research will examine the usefulness of cannabis formulations as standalone treatments and in combination with existing chemotherapy drugs, such as Abraxane.
Pancreatic cancer, the 11th most prevalent cancer diagnosed in Australia, is difficult to detect in the early stages and is highly aggressive. Only 6 per cent of sufferers survive for five years following diagnosis.
“After years of slow progress in the field of pancreatic cancer treatment, we hope to finally open the path to new therapies for pancreatic cancer,” Curtin University’s Professor Marco Falasca said.